Login / Register
Architecture and Design
The Long View
Special issue archive
3-D New Development Map
The Real Deal New York
Morgan Stanley lends Werner and partners $150M for Pfizer HQ buy
July 11, 2018 10:14AM
Morgan Stanley is providing David Werner and his partners $150 million to finance their purchase of Pfizer’s headquarters in Midtown East, sources told The...
Here is how Pfizer’s sale-leaseback stacks up to other big deals
April 12, 2018 01:10PM
Mark Maurer and Rich Bockmann
In 2016, Pfizer embarked on a daunting task: a search for both the buyer of its longtime two-building headquarters on East 42nd Street and...
David Werner buying Pfizer’s Midtown HQ for $360M
April 10, 2018 09:16AM
UPDATED, 2:03 p.m., April 10: As it finalized its new lease at a proposed Hudson Yards skyscraper, Pfizer struck a deal to sell its...
Ethnic tensions flare up over Rabsky’s plans for the Pfizer site
October 10, 2017 09:10AM
UPDATED, Oct. 10, 10:22 a.m.: The dispute over the Rabsky Group’s Pfizer development site in Williamsburg is turning into an ethnic conflict, pitting Hispanic...
City Planning signs off on rezoning of Rabsky’s Pfizer sites
September 19, 2017 12:20PM
The City Planning Commission on Tuesday signed off on rezoning a group of Brooklyn properties — known as the Pfizer sites — owned by...
Pfizer doesn’t want to waste time in signing huge lease deal with Tishman Speyer
August 29, 2017 08:00AM
Pfizer is aiming to ink a lease at Tishman Speyer’s Spiral tower by early 2018. The pharmaceutical giant plans to take 800,000 square feet...
Pfizer to move HQ to Tishman Speyer’s Spiral
August 25, 2017 08:13AM
After months of shopping, Pfizer will move its headquarters from Midtown to Hudson Yards, where it plans to anchor Tishman Speyer’s new office tower,...
Does the proposed Midtown East rezoning incentivize Pfizer to skip town?
June 20, 2017 04:08PM
The density boost that the Pfizer headquarters will automatically get under the Midtown East rezoning means that the pharmaceutical giant has a great reason...
Plans filed for “upscale religious housing” at former Pfizer site
March 24, 2017 03:00PM
UPDATED: Wednesday, March 29 at 12:31 p.m.: Developer Abraham Brach and Parkview Management plan to build a mixed-use apartment building at Pfizer’s former site...
Pfizer sells last piece of its Broadway Triangle site for $28M
January 05, 2017 04:00PM
Pfizer sold the last remaining piece of its development site at Brooklyn’s Broadway Triangle. Developer Abraham Brach paid $27.5 million for the property and...
Pfizer testing out brokers to sell Midtown East buildings
December 21, 2016 10:10AM
Pharmaceutical giant Pfizer, which is gearing up to move to a new headquarters, is on the hunt to find brokers who can help it...
Pfizer looks to sell Midtown East HQ by the end of 2017
October 07, 2016 09:03AM
Global pharmaceutical giant Pfizer is looking to sell its headquarters in Manhattan, a property that is becoming a contentious sticking point in the proposal...
Gaia pays $14.6M for Corinthian floor, plans condo conversion
December 13, 2013 12:52PM
Midtown-based investment firm Gaia Real Estate acquired the 50th floor of the Bernard Spitzer-developed Corinthian condominium tower in Murray Hill from pharmaceutical giant Pfizer,...
Pfizer-owned development site trades for $12.75M
September 11, 2012 12:30PM
Pharmaceutical giant Pfizer has sold off the last of its big holdings in Williamsburg — a vacant development site on Wallabout Street — for...
Durst sells Third Avenue office space to counteract weak leasing market
September 04, 2012 08:30AM
Third Avenue’s weak office marketcompelled the Durst Organization to take a different approach to finding tenants for its building at 205 East 42nd Street,...
Thanks to large vacancies, Third Avenue is city’s weakest office submarket
May 14, 2012 11:30AM
The softest portion of Midtown’s struggling office market is along Third Avenue between East 38th and East 60th streets, according to Crain’s. The avenue’s...
Pfizer sells Williamsburg plots
April 18, 2012 11:00AM
Pharmaceutical giant Pfizer announced that it will sell two large parcels in South Williamsburg to a newly formed venture for an undisclosed price, Crain’s...
Pfizer, JPMorgan put huge swaths of Midtown sublease space on market
March 30, 2012 09:00AM
As if the city’s office leasing market needed any more negative news, Pfizer and JPMorgan are seeking to sublet nearly 325,000 square feet of...
Former W’burg Pfizer plant to become food production center
February 21, 2012 11:30AM
Fermented tea company Kombucha Brooklyn, Brooklyn Soda Works, and Steve’s Ice Cream have all inked leases at a new 660,000-square-foot Culinary Production Facility On...
Former Pfizer tower stake goes for $100M
March 30, 2011 09:30AM
TIAA-CREF has sold a 49.99 percent stake in 685 Third Avenue to the Australian Future Fund Board of Guardians for $100.3 million, according to...
Real estate has found its answer to startup culture in Opportunity Zones, panel says
Real estate execs say Amazon “is great” for New York but question if the city’s infrastructure can sustain new residents
Aby Rosen nixed condo plans at this Tribeca site. Now another developer is giving it a shot
Brooklyn’s tallest tower may soon rise thanks to massive Silverstein loan
Brookfield turns to Apollo Global for financing on 666 Fifth Avenue
November 2018 issue
Digital Ad Products
Join over 200,000 real estate professionals who receive our daily newsletter
All rights reserved © 2018
The Real Deal
is a registered Trademark of Korangy Publishing Inc.
450 West 31st Street